Directors

Maarten De Vos, Director

Maarten De Vos is Associate Professor at the IBME, in the University of Oxford, following a Junior Professorship at the University of Oldenburg, Germany. His academic work focuses on innovative biomedical monitoring and signal analysis, in particular the derivation of biosignatures of patient health from data acquired via wearable sensors and the incorporation of smart analytics into unobtrusive systems.

He has a strong interest in translational research and consults for different digital health and medical innovation companies. His pioneering research in the field of mobile real-life brain-monitoring led to the formation of mBrainTrain, which he supported with scientific advise and which has won several prizes for their mobile EEG innovation. His work on neonatal brain monitoring also achieved impact in patient care through the Neoguard implementation project. After successful completion of the Biodesign faculty training at Stanford University, he started the Oxford Biodesign programme.

Jeroen Bergmann, Co-Director

Jeroen Bergmann heads the Natural Interactions Lab for preventative and assistive technologies at Oxford University, is the Co-Director of the Oxford Biodesign programme, and is a BBSRC FLIP fellow researching new ways to monitor human performance using body sensor networks. His work focuses on the development, design and application of preventative technology. Active projects consist of the development of wearables for physical activity monitoring in extreme conditions, new solutions for limb-deficient patients and user-centred design for rehabilitation and prevention.

Jeroen co-founded a mobility aid company that designed new aids. He worked on a range of industry-academic led projects in affiliation with MIT, consulted for several companies and helped secure governmental business funding from Innovate UK for R&D. He was selected for an international competitive accelerator program and is involved in developing clinical trials for medical devices.

 

 

Programme

  1. Our Mission
  2. Outline of Training Programme
  3. Identify
  4. Invent
  5. Incubate
  6. Short Programme
  7. Resources
  8. GaitThaw Project Wins Prize at the EIT Health UK-Ireland Competition

People

  1. Fellows
  2. Steering Committee

Partners

  1. Contributors
  2. Supporters

BioEscalator

  1. About Oxford BioEscalator

News & Events

  1. Latest News
  2. Events & Workshops

Contact

Directors

Maarten De Vos, Director

Maarten De Vos is Associate Professor at the IBME, in the University of Oxford, following a Junior Professorship at the University of Oldenburg, Germany. His academic work focuses on innovative biomedical monitoring and signal analysis, in particular the derivation of biosignatures of patient health from data acquired via wearable sensors and the incorporation of smart analytics into unobtrusive systems.

He has a strong interest in translational research and consults for different digital health and medical innovation companies. His pioneering research in the field of mobile real-life brain-monitoring led to the formation of mBrainTrain, which he supported with scientific advise and which has won several prizes for their mobile EEG innovation. His work on neonatal brain monitoring also achieved impact in patient care through the Neoguard implementation project. After successful completion of the Biodesign faculty training at Stanford University, he started the Oxford Biodesign programme.

Jeroen Bergmann, Co-Director

Jeroen Bergmann heads the Natural Interactions Lab for preventative and assistive technologies at Oxford University, is the Co-Director of the Oxford Biodesign programme, and is a BBSRC FLIP fellow researching new ways to monitor human performance using body sensor networks. His work focuses on the development, design and application of preventative technology. Active projects consist of the development of wearables for physical activity monitoring in extreme conditions, new solutions for limb-deficient patients and user-centred design for rehabilitation and prevention.

Jeroen co-founded a mobility aid company that designed new aids. He worked on a range of industry-academic led projects in affiliation with MIT, consulted for several companies and helped secure governmental business funding from Innovate UK for R&D. He was selected for an international competitive accelerator program and is involved in developing clinical trials for medical devices.